During the past decade, University of Cincinnati Department of Psychiatry and Behavioral Neuroscience conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 9 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Cincinnati Department of Psychiatry and Behavioral Neuroscience" #1 sponsor was "University of Cincinnati" with 6 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Sunovion" with 4 trials sponsored, "Supernus Pharmaceuticals, Inc." with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Cincinnati Department of Psychiatry and Behavioral Neuroscience" #1 collaborator was "National Institute of Mental Health (NIMH)" with 3 trials as a collaborator, "DSM Nutritional Products, Inc." with 1 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Cincinnati Department of Psychiatry and Behavioral Neuroscience" are "Attention Deficit Hyperactivity Disorder" (4 trials), "Depression" (4 trials), "Depressive Disorder, Major" (3 trials), "Anxiety" (2 trials) and "Adult Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "University of Cincinnati Department of Psychiatry and Behavioral Neuroscience" in a lesser frequency.

Most popular intervention types in "University of Cincinnati Department of Psychiatry and Behavioral Neuroscience" are "Drug" (22 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Dasotraline" (3 trials), "Escitalopram" (3 trials), "Esketamine" (2 trials) and "SPN-810" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Cincinnati Department of Psychiatry and Behavioral Neuroscience" are 22 trials for "All" genders.

Currently, there are NaN active trials in "University of Cincinnati Department of Psychiatry and Behavioral Neuroscience". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in University of Cincinnati Department of Psychiatry and Behavioral Neuroscience, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Cincinnati Department of Psychiatry and Behavioral Neuroscience, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".